Canada - Cardiac Glycosides Use
Since 2014, Canada Cardiac Glycosides Use was down by 9.4% year on year. In 2019, the country was ranked number 19 comparing other countries in Cardiac Glycosides Use with 1.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Latvia lead the ranking with 3 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a fall of 3.2% compared to 2018. Netherlands recorded the best 5 years average growth at -4.4% per year, while Chile witnessed the worst performance at -18.6% per year.
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 1.10 |
| 2018 | 1.30 |
| 2017 | 1.40 |
| 2016 | 1.60 |
| 2015 | 1.70 |
Download all data from 2007 to 2019
How does Canada rank in Cardiac Glycosides Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
3 | 2019 | -6.3 % | -5.1 % | View data | |
| 1 |
#1
Latvia
|
3 | 2019 | -3.2 % | -5.1 % | View data | |
| 16 |
#16
Italy
|
2 | 2019 | -5.6 % | -8.8 % | View data | |
| 19 |
#19
Canada
|
1 | 2019 | -15.4 % | -9.4 % | View data | |
| 19 |
#19
Greece
|
1 | 2019 | +10.0 % | -14.4 % | View data | |